Wednesday, November 20, 2013
Print Current Session:
|
|
Wednesday
SESSION 40:
OTHER NEW DEVELOPMENTS IN THE MANAGEMENT OF VENOUS DISEASE
Moderators:William A. Marston, MD / Thomas W. Wakefield, MD
|
|
SESSION 40 SCHEDULE | |
1:00 PM - 1:05 PM | Tips And Tricks For Improving Treatment Of Venous Ulcers |
Presenter(s):Albeir Y. Mousa, MD | |
1:06 PM - 1:11 PM | SVS/AVF Guidelines For Venous Ulcer Management: How Can Costs Be Minimized |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
1:12 PM - 1:17 PM | A Workable Plan For The Endovenous Treatment Of Leg Ulcers: How Effective Is It And How Many Patients Are Eligible: A New Horizon For Vascular Specialists |
Presenter(s):Seshadri Raju, MD | |
1:18 PM - 1:23 PM | Important Vascular Changes During Pregnancy And Their Implications For The Vascular Surgeon And Vascular Specialist |
Presenter(s):Joann Lohr, MD | |
1:24 PM - 1:29 PM | When Should Acute DVT Be Treated Aggressively By Endovascular Means And When Is Conservative Treatment Best: What Is The Optimal Treatment |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
1:30 PM - 1:35 PM | What The Vascular Specialist Needs To Know About The Newer Oral Anticoagulants, Their Pitfalls And How To Use Them |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
1:36 PM - 1:41 PM | New Techniques For Treating Central Vein Occlusions And SVC Syndrome Which Minimize The Use Of Stents: Why It Is Worthwhile |
Presenter(s):Thomas O. McNamara, MD | |
1:42 PM - 1:47 PM | Aggressive Treatment Of Central Vein Stenoses In Patients With Threatened A-V Dialysis Access |
Presenter(s):Karl A. Illig, MD | |
1:48 PM - 1:53 PM | FDA Perspective On Evaluating Procedures And Devices For Treating Venous Disease – Including CCSVI |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD | |
1:54 PM - 2:04 PM | Panel Discussion |
END OF SESSION 40 | |
previous | next |